C10H14ClN; MW: 183.68

C10H14ClN; MW: 183.68

Chemizon is a rapidly growing drug discovery company with operations in the US, Korea and China. Chemizon’s co-founder and CEO, Dr. Tony Piscopio was a co-founder of Array Biopharma, a leading biotech company located in Boulder, Colorado, USA and served as its VP of Chemistry for nine years. Chemizon’s management team brings a high level of expertise to the IND generation process having successfully brought forward several candidates to clinical trials. Chemizon’s core competency lies in drug discovery: we assist our partners in converting their target know-how into breakthrough medicines. Our team brings considerable experience to a wide range of therapeutic areas including oncology, inflammation, cardiovascular, CNS, anti infective and metabolic diseases. Our goal is to accelerate our collaborator’s drug discovery efforts using a vertically integrated discovery platform that includes Progenitors Leadz ADMET and radiolabeling capabilities. Chemizon’s technical team aims to develop quality, ‘best-in-class’ candidates that can better survive the rigors of the development process. Research collaborations are undertaken at two world class facilities: a 15,000 sq ft facility in the Seongnam Biotech hub, Seoul, Korea and a 36,000 sq ft facility located at the prestigious Tsinghua Science Park in Beijing, China. Both facilities are equipped with a superb IT infrastructure, kilo labs and state-of-the-art analytical suites (including 400 NMR, LC-MS and LC). Video conferencing capabilities and VPN’s enable seamless communication and secure data transfer with our partners who have immediate access to time-critical information. Asia has grown significantly in terms of providing quality service in the past decade and western pharmaceuticals have taken notice. While advanced intermediates, process development, custom synthesis are now routinely outsourced to Asia, drug discovery partnering is still in its infancy. Drug discovery, unlike some other areas in the life sciences cycle, requires expertise in medicinal chemistry, biology and pharmacokinetics along with a clear understanding of the steps involved with filing a successful IND application. Chemizon, with its repatriated management and technical teams is ideally positioned to become the partner of choice for life science organizations seeking to cost effectively accelerate their drug discovery programs.